Dapagliflozin Enhances Glycemic Control When Added to Evogliptin and Metformin in Type 2 Diabetes Patients: Study Medha Baranwal13 Sept 2024 9:45 AM ISTKorea: A recent randomized, double-blind, placebo-controlled study has revealed promising results for adding dapagliflozin to an existing regimen of...
Genetic Study links High Insulin to Lower Lp(a) Levels, Offers New Insights into Type 2 Diabetes Risk Medha Baranwal13 Sept 2024 9:30 AM ISTPoland: A recent Mendelian randomization (MR) study published online in Cardiovascular Diabetology reveals a link between genetically predicted higher...
Research Finds Semaglutide's Cardiovascular Benefit Effective Even in Impaired Kidney Function Patients Dr. Garima Soni13 Sept 2024 8:30 AM ISTThe anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as...
Tirzepatide effects greater weight loss among women compared to men, claims study Dr. Kamal Kant Kohli13 Sept 2024 8:00 AM ISTAll doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but...
Research Finds Rapid Glycemic Control In Gestational Diabetes Can Reverse Child's Obesity Risk Dr. Garima Soni13 Sept 2024 7:45 AM ISTSwiftly achieving glycaemic control after a diagnosis of gestational diabetes can bring the baby's risk of obesity in childhood down to a level...
Semaglutide improves heart health outcomes beyond weight loss: ESC 2024 Dr. Kamal Kant Kohli12 Sept 2024 8:15 PM ISTSemaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss,...
Longer Diabetes duration, Strict Glycemic Control Linked to Increased Fracture Risk at Specific Sites: Study Medha Baranwal12 Sept 2024 9:00 AM ISTNetherlands: A new study, published in Diabetes, Obesity and Metabolism sheds light on how various characteristics of type 2 diabetes (T2D) are...
13% Weight Loss Achieved Over Three Months With Amycretin: Phase 1 Trial Finds Dr. Garima Soni12 Sept 2024 8:45 AM ISTIndividuals who received a once-a-day oral weight loss drug lost up to 13% of their body weight over three months, new research was presented at the...
8-Hour Eating Window Improves Glucose Control in Type 2 Diabetes, Regardless of Timing: Randomised Crossover Trial Finds Dr. Garima Soni12 Sept 2024 8:15 AM ISTRestricting the eating window to 8 hours a day significantly improves blood glucose control in adults at risk of type 2 diabetes irrespective of...
Study Reveals Significant Care Gap in SGLT2 Inhibitor Use for Diabetes and HF, Despite Real-World Benefits Medha Baranwal11 Sept 2024 9:45 AM ISTRecent study highlights a significant care gap due to the underuse of SGLT2 inhibitors, despite their benefits.Canada: A recent population-level...
New Meta-Analysis Finds Targeted Vitamin D Intervention Strategies Effective for Cardiometabolic Health Dr. Garima Soni11 Sept 2024 8:45 AM ISTA latest systematic review and meta-analysis conducted by scientists from institutions across China and the United States has uncovered promising...
Patients receiving steroids more than twice as likely to develop diabetes, finds UK study Dr. Kamal Kant Kohli11 Sept 2024 8:30 AM ISTPatients who are being treated with systemic glucocorticoids are more than twice as likely to develop diabetes as those not receiving the treatment,...
